A comparative study of intratracheal and aerosolization instillations of bleomycin inducing experimental lung fibrosis in rat

References

• Abidi A, Robbe A, Kourda N, Ben Khamsa S, Legrand A. 2017a. Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model. Biomed Pharmacother. 90:626–637.
   PubMed Web of Science ®Google Scholar
• Abidi A, Serairi R, Kourda N, Ben Ali R, Ben Khamsa S, Feki M. 2016. Therapeutic effect of flaxseed oil on experimental pulmonary fibrosis induced by bleomycin in rats. Eur J Inflamm. 14:133–143.
   Web of Science ®Google Scholar
• Abidi A, Aissani N, Sebai H, Serairi R, Kourda N, Ben Khamsa S. 2017b. Protective effect of Pistacia lentiscus oil against bleomycin-induced lung fibrosis and oxidative stress in rat. Nutrition and Cancer1–8.
   Web of Science ®Google Scholar
• Aebi H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126.
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson JM, Timbrell V. 1998. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 41:467–470.
   Web of Science ®Google Scholar
• Bahri S, Ben Ali R, Gasmi K, Mlika M, Fazaa S, Ksouri R, Serairi R, Jameleddine S, Shlyonsky V. 2017. Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis. Pharm Biol. 55:462–471.
   PubMedGoogle Scholar
• Beyer WJR, FridovIch I. 1987. Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem. 161:559–566.
   PubMed Web of Science ®Google Scholar
• Cordier J-F. 2014. Idiopathic pulmonary fibrosis: advances in etiology, diagnosis and treatment. Bull Acad Natle Méd. 198:1353–1366.
   PubMed Web of Science ®Google Scholar
• Cottin V, Cordier JF. 2008. Idiopathic pulmonary fibrosis. Presse Med. 37:1581–1590.
   PubMed Web of Science ®Google Scholar
• Delaney J, Neville WA, Swain A, Miles A, Leonard MS, Waterfield CJ. 2004. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers. 9:271–290.
   PubMed Web of Science ®Google Scholar
• Della Latta V, Cecchettini A, Del Ry S, Morales MA. 2015. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res. 97:122–130.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Ellis DI. 2005. Metabolomics: current analytical platforms and methodologies. Trends Analyt Chem. 24:285–294.
   Web of Science ®Google Scholar
• Hasegawa-Baba Y, Kubota H, Takata A, Miyagawa M. 2014. Intratracheal instillation methods and the distribution of administered material in the lung of the rat. J Toxicol Pathol. 27:197–204.
   PubMed Web of Science ®Google Scholar
• Ho C-Y, Lu C-C, Jhang J-J, Yen G-C. 2017. Diallyl sulfide attenuates transforming growth factor-β-stimulated pulmonary fibrosis through Nrf2 activation in lung MRC-5 fibroblast. J Functional Foods. 28:314–320.
   Web of Science ®Google Scholar
• Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, Freitag-Wolf S, Bewig B. 2008. Standardized quantification of pulmonary fibrosis in histological samples. BioTechniques. 44:507–511.
   PubMed Web of Science ®Google Scholar
• Jagirdar J, Lee TC, Reibman J, Gold LI, Aston C, Begin R, Rom WN. 1997. Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect. 105:1197–1203.
   PubMed Web of Science ®Google Scholar
• Kitchin KT. 2001. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol. 172:249–261.
   PubMed Web of Science ®Google Scholar
• Lin PS, Chang HH, Yeh CY, Chang MC, Chan CP, Kuo HY, Liu HC, Liao WC, Jeng PY, Yeung SY, et al. 2016. Transforming growth factor beta 1 increases collagen content, and stimulates procollagen I and tissue inhibitor of metalloproteinase-1 production of dental pulp cells: Role of MEK/ERK and activin receptor-like kinase-5/Smad signaling. J Formos Med Assoc. 116:351–358.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• Lynch JP,3, Huynh RH, Fishbein MC, Saggar R, Belperio JA, Weigt SS. 2016. Idiopathic pulmonary fibrosis: epidemiology, clinical features, prognosis, and management. Semin Respir Crit Care Med. 37:331–357.
   PubMed Web of Science ®Google Scholar
• Michel V, Singh RK, Bakovic M. 2011. The impact of choline availability on muscle lipid metabolism. Food Funct. 2:53–62.
   PubMed Web of Science ®Google Scholar
• Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. 2008. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 40:362–382.
   PubMed Web of Science ®Google Scholar
• Polosukhin VV, Degryse AL, Newcomb DC, Jones BR, Ware LB, Lee JW, Loyd JE, Blackwell TS, Lawson WE. 2012. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice. Exp Lung Res. 38:135–146.
   PubMed Web of Science ®Google Scholar
• Reinert T, Baldotto CSdR, Nunes FAP, Scheliga AAdS. 2013. Bleomycin-induced lung injury. J Cancer Res. 2013:1–9.
   Google Scholar
• Robbe A, Tassin A, Carpentier J, Decleves AE, Mekinda Ngono ZL, Nonclercq D, Legrand A. 2015. Intratracheal bleomycin aerosolization: the best route of administration for a scalable and homogeneous pulmonary fibrosis rat model? BioMed Res Int. 2015:198418.
   PubMedGoogle Scholar
• Ryerson CJ, O'Connor D, Dunne JV, Schooley F, Hague CJ, Murphy D, Leipsic J, Wilcox PG. 2015. Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis. Chest. 148:1268–1275.
   PubMed Web of Science ®Google Scholar
• Szinicz L, Forth W. 1988. Effect of As2O3 on gluconeogenesis. Arch Toxicol. 61:444–449.
   PubMed Web of Science ®Google Scholar
• Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol. 176:127–144.
   PubMed Web of Science ®Google Scholar
• Verrecchia F, Mauviel A. 2007. Transforming growth factor-beta and fibrosis. WJG. 13:3056–3062.
   PubMed Web of Science ®Google Scholar
• Vogel P, Rivera VR, Pitt ML, Poli MA. 1996. Comparison of the pulmonary distribution and efficacy of antibodies given to mice by intratracheal instillation or aerosol inhalation. Lab Anim Sci. 46:516–523.
   PubMedGoogle Scholar
• Wang Y, Bollard ME, Keun H, Antti H, Beckonert O, Ebbels TM, Lindon JC, Holmes E, Tang H, Nicholson JK. 2003. Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues. Anal Biochem. 323:26–32.
   PubMed Web of Science ®Google Scholar
• Wang X-B, Wang W, Zhu X-C, Ye W-J, Cai H, Wu P-L, Huang X-Y, Wang L-X. 2015. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension. Life Sci. 137: 56–64.
   PubMed Web of Science ®Google Scholar
• Wei L, Liao P, Wu H, Li X, Pei F, Li W, Wu Y. 2009. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol Appl Pharmacol. 234:314–325.
   PubMed Web of Science ®Google Scholar
• Wei Y-R, Qiu H, Wu Q, Du Y-K, Yin Z-F, Chen S-S, Jin Y-P, Zhao M-M, Wang C, Weng D, Li H-P. 2016. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis. Exp Lung Res. 42:75–86.
   PubMed Web of Science ®Google Scholar
• Yagi K. 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 15:212–216.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Y, Zhang J, Han Z, Chen A, Pan S, Liang S, Wang S. 2015. System responses to chronic cold stress probed via (1)H NMR spectroscopy in plasma and urine matrices. Mol Biosyst. 11:1425–1433.
   PubMedGoogle Scholar
• Zhang Q, Ye H, Xiang F, Song L-J, Zhou L-L, Cai P-C, Zhang J-C, Yu F, Shi H-Z, Su Y, et al. 2017. miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-beta receptor II. Mol Ther. 25:728–711.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shah DU. 2000. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Exp Mol Pathol. 69:67–78.
   PubMed Web of Science ®Google Scholar
• Zhou XM, Zhang GC, Li JX, Hou J. 2007. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats. J Ethnopharmacol. 111:255–264.
   PubMed Web of Science ®Google Scholar